Our Expert in India
No results available
If you are raising a pre-seed or seed round in India in 2026, the SAFE vs Convertible Note India 2026 decision is no longer a matter of preference, it is a regulatory and tax choice with material consequences. Founders issuing instruments to domestic angels face one set of risks; those accepting foreign capital face a substantially harder compliance path under FEMA and the RBI’s Non-Debt Instrument (NDI) framework.
This article delivers a side-by-side comparison across ten dimensions, FEMA/FDI treatment, ROC filings, tax exposure, enforceability, cost and timing, and ends with a concrete decision framework: choose the SAFE route (structured as an iSAFE or CCPS) when these conditions apply, choose the Convertible Note (CLN) when those conditions apply, and engage a venture capital lawyer the moment any of five specific triggers arise.
A Simple Agreement for Future Equity (SAFE) is a Y Combinator–originated instrument that gives an investor the right to receive equity upon a future qualifying event, typically a priced round, in exchange for an upfront cash payment. It is not debt: there is no maturity date, no interest accrual and no repayment obligation. In the United States, a SAFE is a standalone contractual right. In India, it has no dedicated statutory definition.
That absence of statutory recognition is the central issue. Indian company law, principally the Companies Act, 2013, does not contemplate a freestanding “right to future equity” instrument. To give a SAFE legal form in India, practitioners typically wrap it as one of two recognised securities:
Are SAFE notes valid in India? A bare US-style SAFE, without a CCPS or CCD wrapper, sits in a legal grey zone. It is not expressly prohibited, but it is not a recognised “security” under the Companies Act, 2013. It cannot be reported as equity or debt on the balance sheet with certainty, and an AD bank will struggle to classify it for FEMA reporting. The practical answer: use an iSAFE structured as CCPS or CCD whenever there is any cross-border element, and even in purely domestic rounds where regulatory certainty matters.
Who the SAFE route suits. Founders who need speed (no interest or maturity negotiation), want to defer valuation, and are raising from domestic investors or from foreign investors through a CCPS wrapper with proper FEMA filings. Early-stage companies where the cap table should remain clean until a priced Series A also benefit.
Practical downsides. Investors receive fewer protective rights than under a CLN, no repayment backstop, no interest income, and no creditor priority if the company fails. Sophisticated angels and micro-VCs may insist on a convertible note precisely because the SAFE offers them less downside protection.
A Convertible Note (often called a Convertible Loan Note or CLN) is a debt instrument that converts into equity upon a trigger event, typically a qualifying financing round. Until conversion, it is a loan: it carries a principal amount, an interest rate, and a maturity date. If no qualifying event occurs before maturity, the investor may demand repayment, or, depending on the terms, conversion at a pre-agreed floor valuation.
The RBI’s Foreign Exchange Management (Non-Debt Instruments) Rules formally define a “convertible note” as an instrument issued by a startup company recognised by DPIIT, evidencing receipt of money initially as debt, repayable at the option of the holder, or convertible into equity shares within a period not exceeding five years from the date of issue. This definition, anchored in the NDI Rules and associated FEMA notifications, gives CLNs a clear regulatory home that a bare SAFE lacks.
Key structural features for India:
Who the CLN route suits. Foreign investors (NRIs, foreign nationals, FVCIs, offshore funds) who need FEMA-compliant documentation and a repayment backstop. Investors who want interest income and creditor priority in a downside scenario. Founders who are comfortable with a maturity clock and who may benefit from the investor confidence that the CLN structure provides.
Practical downsides. Longer time to close (FEMA filings, AD bank processing, board and shareholder approvals for debt issuance). Higher legal and compliance costs. The maturity date creates a balance-sheet liability and a potential repayment obligation that can constrain cash flow if the next round is delayed.
| Dimension | SAFE (iSAFE / CCPS) | Convertible Note (CLN) |
|---|---|---|
| Legal classification | Equity-linked instrument (CCPS/CCD under Companies Act, 2013); bare US SAFE has no statutory definition in India | Debt until conversion; formally defined in RBI’s NDI Rules under FEMA |
| FEMA / FDI treatment | CCPS treated as equity (non-debt instrument) under NDI Rules; report via Form FC-GPR on allotment | Defined instrument under NDI Rules; report via Form CN on issuance, Form FC-GPR on conversion |
| ROC / MCA filing triggers | Board resolution + ROC filing (PAS-3) on allotment of CCPS; SH-7 if new class of shares created | Board and shareholder resolutions for borrowing; ROC filing on allotment at conversion (PAS-3) |
| Tax at issuance | No immediate capital gains; CCPS allotment may attract stamp duty (state schedule) | Debt at issuance, interest deductible for company, taxable for investor under Income-tax Act, 1961 |
| Tax at conversion | Conversion of CCPS into equity shares, generally not a taxable transfer event | Conversion may constitute a transfer; watch for deemed-income provisions and transfer-pricing risk |
| Balance sheet treatment | Equity (share capital + securities premium) from day one if structured as CCPS | Current liability (debt) until conversion; interest accrual on P&L |
| Investor protections | No repayment right; no interest; limited downside protection; relies on conversion mechanics (cap/discount) | Repayment right at maturity; interest income; creditor priority in insolvency; stronger downside protection |
| Cost & fees | Lower, simpler documentation, fewer regulatory filings (domestic rounds) | Higher, loan documentation, FEMA filings, AD bank fees, potential stamp duty on loan instruments |
| Timing to close | Fast: typically 1–3 weeks (domestic); 3–5 weeks with FEMA filings (cross-border CCPS) | Slower: typically 3–6 weeks (domestic); 4–8 weeks with FEMA/AD bank processing (cross-border) |
| Enforceability & dispute mechanism | Contract law governs; no statutory repayment remedy; risk of misclassification if instrument not properly wrapped | Clear debt remedy; statutory framework under Companies Act and FEMA; arbitration clauses common |
| If instrument never converts | Investor holds CCPS indefinitely (compulsory conversion terms apply) or instrument lapses per terms, no repayment | Investor can demand repayment of principal + interest at maturity; company faces cash-flow obligation |
Three key takeaways from the comparison.
Each dimension below is structured for quick reference. Where numbers or forms are cited, they are drawn from the authoritative sources listed at the end of this article.
Tax treatment is the dimension where the two instruments diverge most sharply, and where founders most often underestimate risk. The core distinction: a CCPS (iSAFE wrapper) is equity from day one; a CLN is debt until conversion. That classification drives every downstream tax consequence.
| Tax Item | SAFE (iSAFE / CCPS) | Convertible Note (CLN) |
|---|---|---|
| Tax at issuance, founder | No immediate capital gains event; allotment of CCPS to investor at fair value generally does not trigger income for founder; stamp duty on instrument per state schedule | No capital gains at issuance (debt, not equity transfer); company deducts interest expense; stamp duty may apply to loan documentation per state schedule |
| Tax at issuance, investor | No taxable event on subscription; cost of acquisition is amount paid for CCPS | Interest income taxable as income from other sources under Income-tax Act, 1961; TDS obligations on company for interest payments |
| Tax at conversion | Conversion of CCPS into equity shares is generally not treated as a transfer under the Income-tax Act, 1961, no capital gains event at conversion | Conversion of debt into equity may constitute a transfer; risk of deemed income if conversion price diverges from fair market value; transfer-pricing scrutiny possible for cross-border notes |
| Stamp duty | On CCPS allotment, varies by state (Maharashtra, Karnataka, Delhi each have separate schedules); typically modest for share instruments | Potentially on both loan agreement and subsequent share allotment; loan instrument stamp duty can be higher than share allotment duty in some states |
| Capital gains on eventual exit | Standard capital gains treatment per holding period from date of CCPS allotment (not conversion date) | Holding period for capital gains purposes may start from conversion date (equity allotment), not CLN issuance date, shorter holding period may result in higher tax rate |
The practical upshot: the iSAFE/CCPS route is generally more tax-efficient for both founder and investor, particularly at conversion. The CLN introduces interest-income taxation and a potential conversion taxable event that requires careful structuring. Founders using CLNs should obtain a tax memo before signing.
FEMA compliance for convertible instruments is where most founders either over-engineer the process or, more dangerously, ignore it altogether. The key distinction: both instruments require FEMA reporting when a foreign investor is involved, but the CLN has a defined reporting form (Form CN) while the CCPS follows the standard equity reporting pathway (Form FC-GPR).
FEMA compliance checklist (cross-border rounds):
The SAFE vs Convertible Note India cost differential is driven primarily by documentation complexity, regulatory filings, and professional fees.
| Cost / Timing Factor | SAFE (iSAFE / CCPS) | Convertible Note (CLN) |
|---|---|---|
| Legal drafting | Simpler, adapt standard iSAFE/CCPS template; fewer negotiation points | More complex, loan terms, interest, maturity, repayment mechanics, events of default |
| Regulatory filings (domestic) | Board resolution + PAS-3 (allotment); SH-7 if new share class | Board + shareholder resolutions for borrowing; PAS-3 on conversion |
| Regulatory filings (cross-border) | Form FC-GPR (one filing) | Form CN at issuance + Form FC-GPR at conversion (two filings) |
| Typical time to close (domestic) | 1–3 weeks | 3–6 weeks |
| Typical time to close (cross-border) | 3–5 weeks | 4–8 weeks |
For a founder optimising for runway, wanting capital in the bank before a demo day or a product milestone, the CCPS/iSAFE route can shave weeks off the process. The CLN is inherently slower because it introduces debt documentation, AD bank processing, and dual FEMA filings.
This dimension matters most in the downside scenario: the company does not raise a priced round before the instrument matures or before cash runs out.
Several regulatory developments between 2024 and 2026 have sharpened the SAFE vs Convertible Note India choice:
The net effect of these changes: using an off-the-shelf US SAFE with foreign investors in India creates more regulatory risk in 2026 than it did even two years ago. Founders should treat the instrument choice as a compliance decision, not merely a commercial one.
Choose SAFE (iSAFE / CCPS) when:
Choose Convertible Note (CLN) when:
| If your priority is… | Choose… |
|---|---|
| Speed and low cost (domestic round) | SAFE (iSAFE / CCPS) |
| FEMA regulatory certainty (foreign investor) | Convertible Note (CLN) |
| Clean equity balance sheet from day one | SAFE (iSAFE / CCPS) |
| Investor downside protection / repayment right | Convertible Note (CLN) |
| Deferring valuation with minimal negotiation | SAFE (iSAFE / CCPS) |
| Interest income for investor during holding period | Convertible Note (CLN) |
| Company lacks DPIIT recognition + has foreign investor | SAFE (structured as CCPS with FC-GPR filing) |
Not every seed round requires a full legal engagement, but these five triggers should prompt you to retain experienced venture capital counsel immediately:
This article was produced by Global Law Experts. For specialist advice on this topic, contact Parag Srivastava at Bombay Law Chambers, a member of the Global Law Experts network.
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 4 hours ago
posted 5 hours ago
posted 5 hours ago
posted 6 hours ago
posted 6 hours ago
posted 6 hours ago
posted 7 hours ago
posted 7 hours ago
No results available
Find the right Legal Expert for your business
Sign up for the latest legal briefings and news within Global Law Experts’ community, as well as a whole host of features, editorial and conference updates direct to your email inbox.
Naturally you can unsubscribe at any time.
Global Law Experts is dedicated to providing exceptional legal services to clients around the world. With a vast network of highly skilled and experienced lawyers, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Global Law Experts is dedicated to providing exceptional legal services to clients around the world. With a vast network of highly skilled and experienced lawyers, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Send welcome message